If the Supreme Court invalidates Affordable Care Act subsidies for consumers on the federal exchange, states without their own Marketplaces will be unlikely to stave off "immediate destabilization" of their insurance market, according to experts.
After the Supreme Court decided to hear King v. Burwell, the case that questions the legality of Affordable Care Act (ACA) subsidies for people who purchase health insurance on the federally run Marketplace instead of the state-run Marketplaces, experts predicted that a win for the plaintiffs would be enough to cripple the healthcare reform law.
While some argue that a decision invalidating the ACA subsidies on the federal exchange would cause states that have refused to create exchanges to move quickly to restore tax credits to middle-class citizens, and HHS would help by relaxing rules. However, in a piece written for the New England Journal of Medicine (NEJM), Nicholas Bagley, JD, David K. Jones, PhD, and Timothy Stoltzfus Jost, JD, explain that it won’t be easy.
“If the IRS rule is invalidated—and absent effective contingency planning—a state that has declined to create its own exchange probably won't be able to stave off the immediate destabilization of its insurance market,” they wrote.
If the Court sides with the plaintiffs, enrollees who are unwilling or unable to pay for their insurance premiums without financial assistance could lose their coverage 30 days after they fail to pay. The authors predict that those who remain in the exchanges will likely be sicker than those who drop their coverage, which in turn will expose insurers to large, unanticipated losses.
Once the Court announces its opinion—expected in late June—the decision could take effect in roughly 25 days. Even if the states using HealthCare.gov could set up their own exchanges quickly enough to reduce or prevent any gaps in coverage, they still might be unwilling to do so. As the authors point out, the political climate in nearly all of the federal exchange states is hostile to the ACA.
Six states on the federally facilitated Marketplace—Alabama, Georgia, Nebraska, Oklahoma, South Carolina, and West Virginia—filed a joint brief supporting the ACA subsidy challenge.
“As a collection of states, we support the ACA challenge that will be decided by the Supreme Court and are hopeful a ruling in our favor will ensure the IRS and other executive agencies are held accountable to enforce the laws as written by Congress,” Oklahoma Attorney General Scott Pruitt said in a statement.
An Oklahoma federal judge has already ruled that the subsidies for premiums could only be granted to enrollees on the state-run exchanges.
“ACA supporters thus have good reason to worry,” the authors concluded in their NEJM perspective piece. “For at least several years, and perhaps for much longer, the outcome in King could determine whether millions of people continue to have access to affordable, comprehensive health insurance.”
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More